Robert Belajic, OD
Optometrist · Auburn, CANPI 1952485427
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $441 of the $527 with a category attached, or 83.8%. 7 manufacturers reported payments, led by Optovue, Inc. at 46.4% of the total. Reporting peaked in 2019 at $350 and has fallen 89.9% since, to $35 in 2024. That places this record below the midpoint for optometrist clinicians in CA, where the typical reported total is $563.
Across 16 payments — averaging $32.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optovue, Inc.$244
- Alcon$139
- Biotissue Holdings Inc.$61
- Thea Pharma Inc.$29
- Oyster Point Pharma, Inc.$24
- Shire North American Group Inc$19
- plus $11 from 1 others
What the payments were for
- Food & beverage$44184%
- Entertainment$8516%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optovue, Inc. | 4 | $244 |
| Alcon | 4 | $139 |
| Biotissue Holdings Inc. | 3 | $61 |
| Thea Pharma Inc. | 2 | $29 |
| Oyster Point Pharma, Inc. | 1 | $24 |
| Shire North American Group Inc | 1 | $19 |
| NEW World Medical,inc. | 1 | $11 |
How this compares
$527 in reported general payments places this provider in the 45th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 17 | $22,407 |
| Cyclosporine | 18 | $9,170 |
| Latanoprost | 164 | $2,922 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 30 | $527 |
| Timolol Maleate | 47 | $448 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Auburn
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Steven FerrucciSepulveda$272K
- Katie ChuRosemead$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.